About: Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy
Creator	Siciliano, Gabriele Angelini, Corrado
Source	Medline; PMC
abstract	The risk of a severe course of COVID-19 is increased in patients suffering with Neuromuscular disorders (NMD) due to the following comorbidities: muscular weakness of the chest and diaphragm, use of ventilator supports and/or presence of tracheostoma, weak airway clearance, cardiac involvement, rhabdomyolysis, comoribities, steroid and immunosuppressant treatments. NMD display varying levels of disability in people with the same diagnosis, thus it is difficult to give COVID-19 related general recommendations. Present advicess were designed for patients, caregivers, general neurologists and non-specialist medical providers. They address frequently asked questions and basic service requirements and are supported by a series of in-depth references. In this truly unprecedented situation, the clinical management of neuromuscular patients during the COVID-19 epidemics - taking into account the related difficulties (patients who have suspended ERT, difficulty in contacting the doctors, etc.) - we propose to use a telemedicine device, i.e. the AIGkit application (AIGkit app), promoted and developed in 2018 by Fabrizio Seidita on behalf of the Italian Glycogenosis Association (AIG). The app was born to allow patients with Pompe disease to receive as far as possible continuous monitoring of their health. The support of all colleagues of the Italian Association for Myology (AIM) should extend its use to all NMD patients and beyond.
has issue date	2020-06-22(xsd:dateTime)
bibo:doi	10.4081/ejtm.2019.9032
bibo:pmid	32782765
has license	cc-by-nc
sha1sum (hex)	eafd7b7f7ca04655b5c8d62b95fdd572a4e75cc1
schema:url	https://doi.org/10.4081/ejtm.2019.9032
resource representing a document's title	Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy
has PubMed Central identifier	PMC7385692
has PubMed identifier	32782765
schema:publication	Eur J Transl Myol
resource representing a document's body	covid:eafd7b7f7ca04655b5c8d62b95fdd572a4e75cc1#body_text
is schema:about of	named entity 'app' named entity 'Association' named entity 'address' named entity 'Association' named entity 'monitoring' named entity 'DIAPHRAGM' named entity 'CONTINUOUS' named entity 'CLINICAL MANAGEMENT' named entity 'RECEIVE' named entity 'MONITORING' named entity 'patients' named entity 'patients' named entity 'diaphragm' named entity 'Present' named entity 'rhabdomyolysis' named entity 'general' named entity 'muscular weakness' named entity 'born' named entity 'application' named entity 'Pompe disease' named entity 'Neuromuscular disorders' named entity 'comorbidities' named entity 'epidemics' named entity 'steroid' named entity 'COVID-19' named entity 'Neuromuscular diseases' named entity 'AIG' named entity 'triaging' named entity 'smartphone' named entity 'ventilatory support' named entity 'COVID-19' named entity 'March 2020' named entity 'motor ability' named entity 'Covid-19' named entity 'intensive care' named entity 'Bozen' named entity 'infection' named entity 'Deflazacort' named entity 'AIG' named entity 'March 16, 2020' named entity 'Google' named entity 'ageusia' named entity 'neuromuscular diseases' named entity 'clinical trials' named entity 'family doctor' named entity 'emotional state' named entity 'Immunosuppression' named entity 'Covid' named entity 'myofiber' named entity 'difficulty walking' named entity 'intravenous immunoglobulin' named entity 'gene' named entity 'cardiomyopathy' named entity 'rituximab' named entity 'gene' named entity 'Covid' named entity 'Inpatient admission' named entity 'Italian' named entity 'neurological' named entity 'HIV' named entity 'Covid' named entity 'pharmacy' named entity 'impact of Covid-19' named entity 'locus' named entity 'Association of British Neurologists' named entity 'steroids' named entity 'Italy' named entity 'e-mail' named entity 'inflammatory muscle disease' named entity 'ventilator' named entity 'biopsy' named entity 'Milan' named entity 'ERT' named entity 'AIG' named entity 'COVID19' named entity 'ventilator' named entity 'AIG' named entity 'infection' named entity 'FVC' named entity 'neurologists'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software